Monitoring Metered Dose Inhalation (MDI) Volume and Timing With a Respimetrix Device in Obstructive Lung Disease.
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 74
- 试验地点
- 1
- 主要终点
- Change in pressurized metered-dose inhaler (pMDI) performed after training using Respimetrix device
研究概览
简要总结
To Determine whether use of the Respimetrix flow test device a) can determine "good" versus "poor" inhaler techniques, and b) the effects of the inhaler training on technique.
详细描述
Good metered dose inhaler (MDI) technique is described as sitting or standing upright with the head slightly tilted back, exhaling fully, and then inhaling slowly and deeply as you activate the MDI. Common mistakes include: not exhaling fully; not inhaling deeply enough; inhaling too quickly, and not activating the MDI at the proper time.
This study will use the Respimetrix device with placebo to assess a patient's inhaler technique, provide training to patients who demonstrate poor inhaler technique, and remotely track a subject's breathing ability over time.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Diagnostic
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients 18 years of age or older
- •Current diagnosis of asthma or Chronic obstructive pulmonary disease (COPD) patients
- •Patients must be willing and able to provide informed consent to participate in the the study.
- •Patients must be able to use a metered dose inhaler
排除标准
- •Contraindication to inhaler use
- •Tracheostomy
- •Incapacitating disability that interferes with the use of the inhaler or execution of the protocol
- •Unable to understand informed consent (e.g. non-English speakers)
研究组 & 干预措施
MDI Training
All participants are led through the MDI training with the Respimetrix Device. Protocol is within groups design.
干预措施: Respimetrix (Device)
结局指标
主要结局
Change in pressurized metered-dose inhaler (pMDI) performed after training using Respimetrix device
时间窗: 2 weeks
Measure actuation timing, flow rate and volume after intervention
次要结局
- Describing baseline pressurized metered-dose inhaler (pMDI) technique(2 weeks)
研究者
Alan Schwartz
Principal Investigator
Pulmonary Critical Care Associates of Baltimore